Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New pegylated HIV fusion inhibitors prepared and tested at Roche

March 17, 2004

SBIR grant supports Chimerix drug development for multidrug-resistant HIV

March 17, 2004

Antiretroviral efficacy of atazanavir plus enfuvirtide in HIV infection

March 9, 2004

Adventrx files IND for BlockAide/CR phase Ib/IIa trials

March 9, 2004

Novel anti-HIV agents in early development at BMS

March 9, 2004

Serostim reduces visceral adipose tissue in HARS study

March 9, 2004

Hemispherx Biopharma cleared to commence phase II Alferon LDO study

March 8, 2004

South African Ampligen study cleared to begin

March 5, 2004

Inhibition of viral replication achieved with TNX-355 in HIV-infected patients

March 1, 2004

AusAm receives contract grant from NIH to accelerate development of DES10

Feb. 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...